TSP1 and MMP9 genetic variants in sporadic prostate cancer

Sana Sfar, Hamadi Saad, Faouzi Mosbah, Sallouha Gabbouj, Lotfi Chouchane

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Angiogenesis plays an important role in the initiation and progression of many malignancies including prostate cancer (PCa). Therefore, genes implicated in angiogenic pathways could be susceptibility candidate genes for this malignancy. In this respect, we investigated the impact of functional genetic variants of TSP1 (N700S) and MMP9 (-1562 C/T) genes on the development and progression of PCa. This case-control study included 101 PCa patients and 106 healthy controls analyzed by polymerase chain reaction -restriction fragment length polymorphism assay. No association was observed between any of the TSP1 genotypes and PCa risk or severity; however, subjects carrying one copy of the MMP9 T allele exhibited threefold higher risk of developing PCa (OR = 2.86; P = 0.004). Regarding prognostic value, a significant association was found between the occurrence of the MMP9 T allele and the high-grade tumor (OR = 3.21; P = 0.004) and the advanced disease (OR = 2.47; P = 0.026). We also analyzed the effect of the combined genotypes on PCa risk. The patients with two high-risk genotypes exhibited 2.8-fold higher risk of developing PCa than those with only low-risk genotypes, but the association was not statistically significant. These findings suggest that MMP9 polymorphism is an independent risk factor of PCa development and aggressiveness.

Original languageEnglish
Pages (from-to)38-44
Number of pages7
JournalCancer Genetics and Cytogenetics
Volume172
Issue number1
DOIs
Publication statusPublished - 1 Jan 2007
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Genotype
Alleles
Genes
Neoplasms
Restriction Fragment Length Polymorphisms
Case-Control Studies
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

TSP1 and MMP9 genetic variants in sporadic prostate cancer. / Sfar, Sana; Saad, Hamadi; Mosbah, Faouzi; Gabbouj, Sallouha; Chouchane, Lotfi.

In: Cancer Genetics and Cytogenetics, Vol. 172, No. 1, 01.01.2007, p. 38-44.

Research output: Contribution to journalArticle

Sfar, Sana ; Saad, Hamadi ; Mosbah, Faouzi ; Gabbouj, Sallouha ; Chouchane, Lotfi. / TSP1 and MMP9 genetic variants in sporadic prostate cancer. In: Cancer Genetics and Cytogenetics. 2007 ; Vol. 172, No. 1. pp. 38-44.
@article{e84a75808a4a4a66be2f7b278bfce961,
title = "TSP1 and MMP9 genetic variants in sporadic prostate cancer",
abstract = "Angiogenesis plays an important role in the initiation and progression of many malignancies including prostate cancer (PCa). Therefore, genes implicated in angiogenic pathways could be susceptibility candidate genes for this malignancy. In this respect, we investigated the impact of functional genetic variants of TSP1 (N700S) and MMP9 (-1562 C/T) genes on the development and progression of PCa. This case-control study included 101 PCa patients and 106 healthy controls analyzed by polymerase chain reaction -restriction fragment length polymorphism assay. No association was observed between any of the TSP1 genotypes and PCa risk or severity; however, subjects carrying one copy of the MMP9 T allele exhibited threefold higher risk of developing PCa (OR = 2.86; P = 0.004). Regarding prognostic value, a significant association was found between the occurrence of the MMP9 T allele and the high-grade tumor (OR = 3.21; P = 0.004) and the advanced disease (OR = 2.47; P = 0.026). We also analyzed the effect of the combined genotypes on PCa risk. The patients with two high-risk genotypes exhibited 2.8-fold higher risk of developing PCa than those with only low-risk genotypes, but the association was not statistically significant. These findings suggest that MMP9 polymorphism is an independent risk factor of PCa development and aggressiveness.",
author = "Sana Sfar and Hamadi Saad and Faouzi Mosbah and Sallouha Gabbouj and Lotfi Chouchane",
year = "2007",
month = "1",
day = "1",
doi = "10.1016/j.cancergencyto.2006.07.014",
language = "English",
volume = "172",
pages = "38--44",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - TSP1 and MMP9 genetic variants in sporadic prostate cancer

AU - Sfar, Sana

AU - Saad, Hamadi

AU - Mosbah, Faouzi

AU - Gabbouj, Sallouha

AU - Chouchane, Lotfi

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Angiogenesis plays an important role in the initiation and progression of many malignancies including prostate cancer (PCa). Therefore, genes implicated in angiogenic pathways could be susceptibility candidate genes for this malignancy. In this respect, we investigated the impact of functional genetic variants of TSP1 (N700S) and MMP9 (-1562 C/T) genes on the development and progression of PCa. This case-control study included 101 PCa patients and 106 healthy controls analyzed by polymerase chain reaction -restriction fragment length polymorphism assay. No association was observed between any of the TSP1 genotypes and PCa risk or severity; however, subjects carrying one copy of the MMP9 T allele exhibited threefold higher risk of developing PCa (OR = 2.86; P = 0.004). Regarding prognostic value, a significant association was found between the occurrence of the MMP9 T allele and the high-grade tumor (OR = 3.21; P = 0.004) and the advanced disease (OR = 2.47; P = 0.026). We also analyzed the effect of the combined genotypes on PCa risk. The patients with two high-risk genotypes exhibited 2.8-fold higher risk of developing PCa than those with only low-risk genotypes, but the association was not statistically significant. These findings suggest that MMP9 polymorphism is an independent risk factor of PCa development and aggressiveness.

AB - Angiogenesis plays an important role in the initiation and progression of many malignancies including prostate cancer (PCa). Therefore, genes implicated in angiogenic pathways could be susceptibility candidate genes for this malignancy. In this respect, we investigated the impact of functional genetic variants of TSP1 (N700S) and MMP9 (-1562 C/T) genes on the development and progression of PCa. This case-control study included 101 PCa patients and 106 healthy controls analyzed by polymerase chain reaction -restriction fragment length polymorphism assay. No association was observed between any of the TSP1 genotypes and PCa risk or severity; however, subjects carrying one copy of the MMP9 T allele exhibited threefold higher risk of developing PCa (OR = 2.86; P = 0.004). Regarding prognostic value, a significant association was found between the occurrence of the MMP9 T allele and the high-grade tumor (OR = 3.21; P = 0.004) and the advanced disease (OR = 2.47; P = 0.026). We also analyzed the effect of the combined genotypes on PCa risk. The patients with two high-risk genotypes exhibited 2.8-fold higher risk of developing PCa than those with only low-risk genotypes, but the association was not statistically significant. These findings suggest that MMP9 polymorphism is an independent risk factor of PCa development and aggressiveness.

UR - http://www.scopus.com/inward/record.url?scp=33845540635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845540635&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2006.07.014

DO - 10.1016/j.cancergencyto.2006.07.014

M3 - Article

VL - 172

SP - 38

EP - 44

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 1

ER -